171
Views
11
CrossRef citations to date
0
Altmetric
Articles

Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time

, , , , , , , , , & show all
Pages 214-218 | Accepted 09 Sep 2011, Published online: 24 Feb 2012

References

  • Pedersen OB, Svendsen AJ, Ejstrup L, Skytthe A, Harris JR, Junker P. Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol 2008;37:120–6.
  • Mathieu A, Cauli A, Fiorillo MT, Sorrentino R. HLA-. B27 and ankylosing spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis. Autoimmun Rev 2008;7:398–403.
  • Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, Bitti PP, . Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27 subjects: a possible further susceptibility factor for the development of disease. Rheumatology 2002;41:1375–9.
  • Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 1993;150:4168–78.
  • Liu SQ, Yu HC, Gong YZ, Lai NS. Quantitative measurements of HLA-B27 mRNA in patients with ankylosing spondylitis – correlation with clinical activity. J Rheumatol 2006;33:1128–32.
  • Jaakkola E, Herzberg I, Laiho K, Barnardo MCNM, Pointon JJ, Kauppi M, . Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis 2006;65:775–80.
  • Schwartz A, Fernández-Repollet E. Primary performance parameters as quality control indicators. Flow Cytometry Standardization Forum 1994;6:9–10.
  • Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, Fleming M, . Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol 2011;186:2672–80.
  • Kollnberger S, Chan A, Sun MY, Chen LY, Wright C, di Gleria K, . Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterodimers, is independent of the sequence of bound peptide. Eur J Immunol 2007; 37: 1313–22.
  • Mear JP, Schreiber KL, Munz C, Zhu X, Stevanovic S, Rammensee H-G, . Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthopathies. J Immunol 1999;163:6665–70.
  • Turner MJ, Sowders DP, DeLay ML, Mohapatra R, Bai S, Smith JA, . HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 2005; 175:2438–48.
  • Goodall JC, Ellis L, Yeo GS, Gaston JS. . Does HLA-B27 influence the monocyte inflammatory response to lipopolysaccharide? Rheumatology 2007;46:232–7.
  • Zhao L, Fong Y, Granfors K, Gu J, Yu D. Identification of cytokines that may enhance the promoter activity of HLA-B27. J Rheumatol 2008;35.826–8
  • Zhao L, Liu CH, Yu D. High-throughput screening of chemical libraries for modulators of gene promoter activity of HLA-B2705: environmental pathogenesis and therapeutics of ankylosing spondylitis. J Rheumatol 2011;38:1061–5.
  • Chung YM, Liao HT, Lin KC, Lin YC, Chou CT, Chen CH, . Prevalence of spondyloarthritis in 504 Chinese patients with HLA-B27-associated acute anterior uveitis. Scand J Rheumatol 2009; 38:84–90.
  • Kim TJ, Na KS, Lee HJ, Lee B, Kim TH. HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol 2009;27:574–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.